期刊文献+

灯盏细辛联合前列地尔治疗老年糖尿病下肢动脉硬化闭塞症25例疗效观察 被引量:5

Efficacy of erigeron breviscapus combined with alprostadil in treating senile diabetic arteriosclerosis obliterans of the lower extremities:A clinical analysis of 25 cases
下载PDF
导出
摘要 目的针对灯盏细辛注射液联合前列地尔治疗老年糖尿病下肢动脉硬化闭塞症的疗效观察。方法 50例老年糖尿病合并下肢动脉硬化闭塞症患者随机分为2组,治疗组采用灯盏细辛注射液联合前列地尔,对照组25例采用前列地尔治疗,疗程2周。结果治疗组总有效率96%,对照组总有效率76%,两组比较有统计学差异(P<0.05),治疗组明显优于对照组。结论灯盏细辛联合前列地尔治疗老年糖尿病下肢动脉硬化闭塞症有较好的疗效。 Objective To explore the clinical efficacy of erigeron breviscapus combined with alprostadil in treating senile diabetic arteriosclerosis obliterans of lower extremities. Methods Fifty patients with senile diabetes complicated with arteriosclerosis obliterans of lower extremities were randomly divided into two groups. The treatment group received lamps asarum injection combined with alprostadil. The control group ( n = 25) received alprostadil treatment. The course of treat- ment was 2 weeks. Results The total efficacy rate of the treatment group was 96 %, and the con- trol group was 76 %. The two groups had statistical difference (P 〈 0.05). The treatment group was significantly better than the control group. Conclusion Erigeron breviseapus combined with al- prostadil in treatment of elderly patients with diabetic arteriosclerosis obliterans of lower extremities has better curative effect.
作者 陈燕霞
出处 《实用临床医药杂志》 CAS 2012年第17期148-149,共2页 Journal of Clinical Medicine in Practice
关键词 灯盏细辛 前列地尔 糖尿病 下肢动脉硬化闭塞症 erigeron breviscapus alprostadil diabetes mellitus arteriosclerosis obliteransof lower extremity
  • 相关文献

参考文献7

二级参考文献13

  • 1徐光,张礼萍,沈慧芬,胡昌奇.野黄芩甙元及其类似物对蛋白激酶C的抑制作用[J].上海医科大学学报,1993,20(3):187-191. 被引量:141
  • 2盛艳梅,张艺,张静,孟宪丽,莫尚武.^(45)Ca同位素技术用于灯盏细辛中抗钙活性有效组分的研究[J].中国药理学通报,2005,21(4):507-508. 被引量:4
  • 3[1]Amos AF, McCarty PJ, Zimmet P. The rising global burden of diabetes and its complications. Estimates and projections to the year 2010,Diab Med,1997,7:85.
  • 4[4]Diabetes Drafting Group. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centers:The world health organization multinational study of vascular disease in diabetics. Diabetologia. 1985,28:615~640.
  • 5陈新谦 金有豫.新编药物学[M]第14版[M].北京:人民卫生出版社,1998.353-364.
  • 6Hoy W,Light A,Megill D.Cardiovascular disease in Navajo Indians with type 2 diabetes.Public Health Rep,1995,110(1):87-94.
  • 7Asakawa H,Tokunaga K,Kawakami F.Comparison of risk factors of macrovascular complications:peripheral vascular disease,cerebral vascular disease and coronary heart disease in Japanese type 2 diabetes mellitus patients.J Diabetes Complications,2000,14(6):307-313.
  • 8Tsujikawa A,Ogura Y,Hirosbiba N,et al.Retinal ischemia reperfusion injury attenuated by blocking of adhesion molecules of vascular endothelium[J].Invest Ophthalmol Vis Sci,1999,40(6):1183-1190.
  • 9Ettaicbe M,Fillacierk,Widmann C,et al.Riluzole improves functional recovery after ischemia in the rat retina[J].Invest Ophthalmol Vis Sci,1999,40 (3):729-736.
  • 10Oka MS,Frederick JM,Lander RA,et al.Adult human retinal cells in culture:Identification of cell types and expression of differentiated properties[J].Exp Cell Res,1985,159(1):127-140.

共引文献680

同被引文献72

  • 1金玉青,洪远林,李建蕊,李曦,王晓晓,吕光华.川芎的化学成分及药理作用研究进展[J].中药与临床,2013,4(3):44-48. 被引量:380
  • 2Elalamy I, Verdy E, Gerotziafas G, et al. Pathogenesis ofvenous thromboembolic disease incancer[J]. Pathol Biol, 2008, 56(4): 184.
  • 3Hillen H F. Thrombosis in cancer patients[J]. Ann Oncol, 2000, 11(3): 273.
  • 4Weiser M A, Cabanillas M, VuK, et al. Diagnostic evalua- tion of patients with a high suspicion of malignancy: comor- bidities and clinical predictors of cancer[J].Am J Med Sci, 2005, 330(1): 11.
  • 5Falanga A, Panova- Noeva M, Russo L. Procoagulant mechanisms in tumour cells[J].Best Pract Res Clin Haema- tol, 2009, 22(1): 49.
  • 6Khorana A A, Kuderer N M, Culakova E, et al. Develop- ment and validation of a predictive model for chemotherapy associated thrombosis[J]. Blood, 2008, 111(10) : 4902.
  • 7Ikeda M, Furukawa H, Imarnura H, et al. Poor prognosis associated with thrombocytosis inpatients withgas- tric can- cer[J].Annals of Surgical Oncology, 2002, 9(3) : 287.
  • 8Tomita M, Shimizu T, Hara M, et al. Prognostic impact ofthrombocytosis in resectable non- small cell lung cancer[J]. Interact Cardiovasc Thorac Surg, 2008, 7(4) : 613.
  • 9Brockmann M A, Giese A, Mueller K, et al. Preoperative thrombocytosis predicts poor survival in patients withg li- oblastoma[J]. Neuro-Oncology, 2007, 9(3): 335.
  • 10吴泉英.凯时配合治疗下肢闭塞性动脉硬化症50例临床观察[J].中国动脉硬化杂志,2007,15(10):792-793. 被引量:6

引证文献5

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部